BioPharma Credit PLC
BOPCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -22.1% | -25.3% | 69.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 69.2% | 86.2% | 69.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 98.2% | 0% | 0% | 0% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 98.2% | 67.9% | 85.3% | 67.2% |
| EPS Diluted | 0.1 | 0.083 | 0.13 | 0.062 |
| % Growth | 20.8% | -36.3% | 110.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |